Integer Corporation

NYSE: ITGR ยท Real-Time Price ยท USD
125.91
-0.40 (-0.32%)
At close: May 01, 2025, 2:26 PM

Integer Revenue Breakdown

Period Ending Dec 31, 2024 Sep 27, 2024 Sep 30, 2016 Jul 1, 2016 Apr 1, 2016
Cardio And Vascular Revenue 708.57M 241.01M 148.27M 144.22M 133.65M
Cardio And Vascular Revenue Growth +194.00% +62.54% +2.81% +7.91% n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 28, 2018 Dec 29, 2017 Dec 30, 2016 Jan 1, 2016 Jan 2, 2015 Jan 3, 2014 Dec 28, 2012
Puerto Rico Revenue 137.06M 108.42M 114.08M 110.16M 96.05M 154.64M 146.5M 133.75M 159.24M 136.9M 127.7M 117.96M 105.73M
Puerto Rico Revenue Growth +26.41% -4.96% +3.55% +14.69% -37.89% +5.56% +9.53% -16.01% +16.32% +7.20% +8.26% +11.57% n/a
Rest Of World Revenue 516.17M 501.25M 423.74M 372.44M 321.74M 341.34M 319.21M 465.88M 352.64M 199.59M 182.24M 113.77M 107.93M
Rest Of World Revenue Growth +2.98% +18.29% +13.78% +15.76% -5.74% +6.93% -31.48% +32.11% +76.68% +9.52% +60.19% +5.41% n/a
United States Revenue 938.67M 897.43M 762.13M 671.5M 596.8M 698.47M 687.26M 862.29M 805.74M 401.38M 312.54M 325.09M n/a
United States Revenue Growth +4.60% +17.75% +13.50% +12.52% -14.56% +1.63% -20.30% +7.02% +100.74% +28.43% -3.86% n/a n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 27, 2024 Jun 28, 2024 Mar 29, 2024 Dec 31, 2023 Sep 29, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jul 1, 2022 Apr 1, 2022 Dec 31, 2021 Oct 1, 2021 Jul 2, 2021 Apr 2, 2021 Dec 31, 2020 Oct 2, 2020 Jul 3, 2020 Apr 3, 2020 Dec 31, 2019 Sep 27, 2019 Jun 28, 2019 Mar 29, 2019 Dec 28, 2018 Sep 28, 2018 Jun 29, 2018 Mar 30, 2018 Dec 29, 2017 Sep 29, 2017 Jun 30, 2017 Mar 31, 2017 Dec 30, 2016 Sep 30, 2016 Jul 1, 2016 Apr 1, 2016 Jan 1, 2016 Oct 2, 2015 Jul 3, 2015 Apr 3, 2015 Jan 2, 2015
Selling, General, and Administrative Revenue 47.47M 33.85M 37.13M 37.84M 45.8M 42.1M 45.83M 41.89M 41.04M 38.2M 41.79M 39.56M 36.27M 34.27M 35.38M 35.5M 35.04M 3.61M 33.9M 36.46M 37.66M 32.94M 33.14M 34.96M 35.14M 34.09M 36.78M 41.24M 42.62M 39.73M 39.72M 39.5M 37.51M 36.27M 37.63M 41.89M 33.51M 22.31M 24.1M 22.61M 24.85M
Selling, General, and Administrative Revenue Growth +40.21% -8.81% -1.89% -17.38% +8.79% -8.13% +9.41% +2.07% +7.44% -8.59% +5.63% +9.08% +5.83% -3.14% -0.35% +1.33% +870.82% -89.35% -7.01% -3.20% +14.35% -0.63% -5.19% -0.53% +3.08% -7.31% -10.81% -3.24% +7.26% +0.02% +0.57% +5.30% +3.43% -3.62% -10.17% +25.01% +50.21% -7.45% +6.61% -9.01% n/a
Research and Development Revenue 10.61M 11.92M 16.1M 15.75M 13.26M 14.54M 16.88M 19.09M 13.84M 16.12M 14.87M 16.08M 12.74M 12.05M 13.74M 13.46M 10.59M 11.89M 12.75M 13.24M 11.81M 11.73M 11.4M 11.6M 10.16M 12.23M 12.94M 14.54M 15.34M 13.61M 12.89M 13.41M 12.64M 11.41M 13.64M 17.31M 13.09M 14.3M 13.06M 12.54M 9.88M
Research and Development Revenue Growth -10.98% -25.96% +2.23% +18.83% -8.82% -13.88% -11.57% +37.94% -14.15% +8.42% -7.54% +26.28% +5.69% -12.29% +2.06% +27.12% -10.96% -6.70% -3.74% +12.13% +0.68% +2.92% -1.72% +14.14% -16.96% -5.42% -11.03% -5.23% +12.74% +5.57% -3.89% +6.07% +10.79% -16.33% -21.18% +32.23% -8.47% +9.46% +4.13% +26.94% n/a